Morphine Sulfate Market Leading Players Analysis Report By 2025
15th
November 2018 - Global
Morphine Sulfate (CAS 64-61-3) Market is expected to rise at a significant CAGR
in the forthcoming years.The dosage for Morphine sulfate (CAS 64-31-3) is
dependent on the patient’s medical conditions and response to the treatment.
The does should not be increased abruptly or the intake should not be exceeded
than the prescribed period. Morphine sulfate tablets are controlled-release
tables with ingredients like cetostearyl alcohol, hydroxyethyl cellulose,
hypromellose, polyethylene glycol, talc, titanium dioxide and magnesium
stearate.
Commercial market driving factors responsible for the growth of morphine
sulfate market includes demand for painkiller antibiotics and other health
conditions. However, the concerned side-effects and health hazards are likely
to impede the market growth. Also, ban in some countries on using morphine
contributes as a restraining factor.
Browse Full
Research Report @ https://www.millioninsights.com/industry-reports/morphine-sulfate-market
Based on segmentation by product, the morphine sulfate (CAS 64-31-3)
includes powder and pills. Pills dominate the segment owing to growth in
prevalence of painkiller and antibiotics. Based on segmentation by end-user,
the morphine sulfate (CAS 64-31-3) includes injection and capsule. Capsule
dominates the market segment owing to rise in demand for solid oral dosage.
Geographically, morphine sulfate (CAS 64-31-3) market spans North
America, Latin America, Europe, Asia-Pacifica, Middle-East and Africa. APAC
market dominate the global market owing to presence of enormous pool of
customers and rise in medical infrastructure. China, India, Japan, South Korea
and Taiwan are leading in the manufacture of the prescribed tablet. North
America and Europe market are also expected to grow at a steady CAGR in the
forthcoming years owing to ban on morphine in some countries due to its bizarre
nature and mode of intake. MEA regions are also expected to rise at a steady
CAGR owing to low demand and developing medical infrastructure.
The key players in the morphine sulfate (CAS 64-31-3) market include
Mallinckrodt Pharmaceuticals, Purdue Pharma, Cepia-Sanofi, Macfarlan Smith, SUN
PHARMA, Qinghai Pharmaceutical, Taj Pharmaceutical and Northeast Pharm.
Request a Free
Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/morphine-sulfate-market/request-sample
Comments
Post a Comment